Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (471-480 of 587) with videos related to

Pageof 59
Sort By:
Toxicology and Applied Pharmacology|October 17, 1998
Scavestrogens protect IMR 32 cells from oxidative stress-induced cell deathD Blum-Degen, M Haas, S Pohli, et al.
Brain & Development|January 1, 1985
Neurochemical aspects of the Rett syndromeP Riederer, T Brücke, E Sofic, et al.
Pharmacopsychiatry|July 25, 2008
The influence of smoking on the serum level of duloxetineM Fric, B Pfuhlmann, G Laux, et al.
Neuroscience Letters|December 21, 2000
The human dopamine transporter gene: the 5'-flanking region reveals five diallelic polymorphic sites in a Caucasian population sampleC Rubie, F Schmidt, M Knapp, et al.
Neuroreport|June 2, 1994
Memantine inhibits [3H]MK-801 binding to human hippocampal NMDA receptorsW Berger, J Deckert, J Hartmann, et al.
Science (New York, N.Y.)|August 17, 1984
Bimodal distribution of dopamine receptor densities in brains of schizophrenicsP Seeman, C Ulpian, C Bergeron, et al.
Journal of Neural Transmission|January 1, 1989
[3H]MK-801 binding sites in postmortem brain regions of schizophrenic patientsJ Kornhuber, F Mack-Burkhardt, P Riederer, et al.
Neuroscience Letters|February 16, 2016
Effects of botulinum toxin type A facial injection on monoamines and their metabolites in sensory, limbic and motor brain regions in ratsS Ibragić, I Matak, A Dračić, et al.
Brain Research|August 20, 1993
Alterations of guanine nucleotide-binding proteins in post-mortem human brain in alcoholicsH Ozawa, Y Katamura, S Hatta, et al.
Pharmacopsychiatry|June 2, 2007
Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidenceS Ulrich, C Hiemke, G Laux, et al.
Pageof 59

Showing results (471-480 of 587) with videos related to

Sort By:
Pageof 59
Toxicology and Applied Pharmacology|October 17, 1998
Scavestrogens protect IMR 32 cells from oxidative stress-induced cell deathD Blum-Degen, M Haas, S Pohli, et al.
Brain & Development|January 1, 1985
Neurochemical aspects of the Rett syndromeP Riederer, T Brücke, E Sofic, et al.
Pharmacopsychiatry|July 25, 2008
The influence of smoking on the serum level of duloxetineM Fric, B Pfuhlmann, G Laux, et al.
Neuroscience Letters|December 21, 2000
The human dopamine transporter gene: the 5'-flanking region reveals five diallelic polymorphic sites in a Caucasian population sampleC Rubie, F Schmidt, M Knapp, et al.
Neuroreport|June 2, 1994
Memantine inhibits [3H]MK-801 binding to human hippocampal NMDA receptorsW Berger, J Deckert, J Hartmann, et al.
Science (New York, N.Y.)|August 17, 1984
Bimodal distribution of dopamine receptor densities in brains of schizophrenicsP Seeman, C Ulpian, C Bergeron, et al.
Journal of Neural Transmission|January 1, 1989
[3H]MK-801 binding sites in postmortem brain regions of schizophrenic patientsJ Kornhuber, F Mack-Burkhardt, P Riederer, et al.
Neuroscience Letters|February 16, 2016
Effects of botulinum toxin type A facial injection on monoamines and their metabolites in sensory, limbic and motor brain regions in ratsS Ibragić, I Matak, A Dračić, et al.
Brain Research|August 20, 1993
Alterations of guanine nucleotide-binding proteins in post-mortem human brain in alcoholicsH Ozawa, Y Katamura, S Hatta, et al.
Pharmacopsychiatry|June 2, 2007
Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidenceS Ulrich, C Hiemke, G Laux, et al.
Pageof 59